Evaxion A (EVAX) Return on Sales (2024 - 2025)
Evaxion A (EVAX) posted Return on Sales of 0.02% for Q1 2026, down 22.01% quarter-over-quarter from 0.01% in Q4 2025, and up 3.0% year-on-year from 0.01% in Q1 2025.
Evaxion A (EVAX) Return on Sales (2024 - 2025) Analysis & Trends
Evaxion A (EVAX) has reported Return on Sales for 3 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.
- Return on Sales for Q1 2026 came in at 0.02%, up 3.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (up 3.0% YoY), and the FY2025 annual result was 0.01%, up 2.0% from the prior year.
- Return on Sales was 0.02% for Q1 2026 at Evaxion A, down from 0.01% in the prior quarter.
- Over five years, Return on Sales peaked at 0.15% in Q1 2024 and troughed at 1.41% in Q2 2025.
- Average Return on Sales over 3 years is 0.23%, with a median of 0.02% recorded in 2026.
- The widest YoY moves for Return on Sales: up 33 bps in 2025, down 98 bps in 2025.
- Over 3 years, Return on Sales stood at 0.34% in 2024, then soared by 96 bps to 0.01% in 2025, then decreased by 22 bps to 0.02% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 0.00% |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 0.00% |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 0.00% |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 0.00% |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 0.00% |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Evaxion A | 1.33 Bn | 1.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.41% |
| Sep 30, 2024 | -0.01% |